Monetary base in Armenia reduced by 1,9% from the beginning of the month making 569.4 billion drams

YEREVAN, February 23. /ARKA/. According to the data of Central Bank of Armenia, monetary base in Armenia reduced by 11.3 billion drams at the beginning of the month compared to the last month making on February 22 over 569.4 billion drams.

In percentage terms, the indicator of monetary base reduced by 1.9%, says the official site of CBA.

Cash money outside CBA was around 360.2 billion drams, reduced by 3.2 billion drams or 0.9% compared to the last month.

Net international reserves (without privatization funds) on February 23 reached 422.4 billion drams, reduced by 13.6 billion drams or 3.3% compared to the beginning of February. ($1- 389.26 drams). -0-

spot_img

POPULAR

The investment portfolio of Armenian banks in the second quarter amounted to 1.93 trillion drams, a decline of 9.5% year-to-date

The total investment portfolio of commercial banks in Armenia at the end of June 2026 amounted to 1,933,341,220 thousand drams, a decrease of 202.38 billion drams, or 9.48%, year-to-date.

Armenian banks’ investments in securities in the second quarter amounted to 1.92 trillion drams

The total volume of investments by Armenian commercial banks in securities as of the end of June 2026 amounted to 1,922,826,829 thousand drams.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img